High-throughput Screening (HTS) Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.80 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
High-throughput Screening (HTS) Market Analysis
The High-throughput Screening Market is poised to grow at a CAGR of nearly 7.8% during the forecast period (2022 - 2027).
The emergence of the COVID-19 pandemic has had an adverse effect on the world economy and the healthcare system. There is a significant impact on the studied market. For instance, according to an article published in October 2021 titled 'Highthroughput screening assays for SARSCoV2 drug development: Current status and future directions, high-throughput screening has proven to be a useful approach for finding new lead compounds for the development of antiviral drugs. It has been observed that the autophagy and AP-1 signaling pathways may be promising targets for COVID-19 therapies through systematic mining of a sizable quantitative high-throughput screening (HTS) database. Thus, COVID-19 has impacted the market growth.
Certain factors that are propelling the market growth are open access to high-throughput screening laboratories, technological advancements in high-throughput screening, and increasing usage in universities and research centers.
Over the past few years, there has been a considerable growth in the number of high-throughput screening (HTS) facilities available to the public. These facilities range in size from modestly equipped university screening facilities to expansive molecular libraries and probe centers networks. These facilities provide a thorough method of probe discovery in academia and use both conventional and cutting-edge assay technology to carry out primary and secondary screening campaigns. One of the significant advantages of these centers was knowledge sharing among scientists, researchers, etc. For instance, the Columbia Genome Center offers high-quality molecular screening services for investigators throughout the Columbia University research community. Also, The European counterpart of the National Institutes of Health (NIH) program, known as EU-open-screen, provides open access to all European companies engaged in chemical biology. The association of high-throughput screening (HTS) centers is intended to provide useful information about the drug or target, or the entire process. Thus, open access provides a better platform for knowledge sharing and can help optimize the entire process, which may drive the demand for HTS technology among end users.
However, the high capital investment and need for extensive automation techniques are likely to hinder the market growth over the forecast period.
High-throughput Screening (HTS) Market Trends
This section covers the major market trends shaping the High-throughput Screening Market according to our research experts:
Pharmaceutical and Biotechnology Firms Segment Expects to Register a High CAGR Over the Forecast Period
The pharmaceutical and biotechnology firms are expected to witness significant growth in the high-throughput screening market over the forecast period owing to the factors such as the increasing development of novel molecules for the treatment of several chronic conditions.
In addition, the growing need for rapid and precise screening of several target molecules, during drug discovery and development phases has led to the adoption of automated high-throughput screening techniques to screen massive chemical and biomarker libraries generated during the research processes.
Furthermore, according to an article published in June 2020, titled 'High-throughput screening as a method for discovering new drugs', fluorescence-based assays are a practical technique to visualize biological responses to compounds in a high-throughput scenario. In addition, as per the same source, a target molecule can be produced or eliminated in fluorescence experiments to cause signals to be released or quenched. This is expected to increase the adoption of high-throughput screening methods in developing drugs, which is anticipated to propel market growth.
With the increasing pharmaceutical spending on research and development, adoption of various business strategies, and advanced technology and the advantages offered by the high-throughput screening such as high sensitivity (single molecule detection), high speed (automation), minimization of the sample (microtiter plate assay), and the ability to detect low background signals, the high-throughput screening methods are being increasingly adopted in the pharmaceutical industry, boosting market growth over the forecast period. According to the data published by the Congressional Budget Office, in 2021, it has been observed that pharmaceutical industries have spent nearly USD 200 billion on research and development in 2020 globally compared to USD 83 million in 2019. Thus, the increasing investment in research and development by the companies further increases the capabilities of the company to adopt innovative technologies in high throughput screening assays, thereby increasing market growth.
Thus, owing to the aforementioned factors, the market is expected to grow significantly during the forecast period.
North America Dominates the Market and Expects to do Same Over the Forecast Period
North America is expected to hold a significant market share in the high-throughput screening market owing to the factors such as the increasing adoption of high-throughput screening, rising research and development expenditure, the growing advances in combinatorial chemistry and the field of genomics, and huge investments by the pharmaceutical industry, for high-throughput screening technologies, in terms of automation, miniaturization, and assay methodology.
The spending on research and development (R&D) by various pharmaceutical companies and government organizations has been increasing recently, which is anticipated to drive market growth over the forecast period. For instance, Danaher Corporation invested USD 1,742 million in its research and development in 2021, as compared to USD 1,348 million in 2020. In addition, Bio-Rad Laboratories Inc.invested USD 879.6 million in 2021 as compared to USD 800.3 million in 2020. Thus, the huge investment by the pharmaceutical industry is expected to propel the market growth over the forecast period.
In addition, the rising company activities in developing products and increasing product launches are expected to boost market growth. For instance, in August 2021, Becton, Dickinson, and Company launched a new, fully automated high-throughput diagnostic system using robotics and sample management software algorithms to set a new standard in automation for infectious disease molecular testing in core laboratories and other centralized laboratories in the United States. This launch made BD Onclarity HPV Assay with extended genotyping for the BD COR System available to the high-throughput labs for processing most cervical cancer screening specimens in the United States with persistent infection with human papillomavirus (HPV).
Thus, owing to the aforementioned factors, the market is expected to grow significantly during the forecast period.
High-throughput Screening (HTS) Industry Overview
The high-throughput screening market is highly competitive and consists of several major players. Most of the major players enjoy a global presence and are facing intense competition in emerging economies. Emerging countries are becoming hotspots of significant competition, due to a rapidly expanding market size, fueled by growing investments in research and development and the recent trend of contract research outsourcing. Some of the key players in the market are Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Merck KGaA, PerkinElmer Inc., Thermo Fisher Scientific Inc. and Beckman Coulter Inc..
High-throughput Screening (HTS) Market Leaders
-
Bio-Rad Laboratories Inc.
-
PerkinElmer Inc.
-
Thermo Fisher Scientific Inc.
-
Merck KGaA
-
Agilent Technologies Inc.
*Disclaimer: Major Players sorted in no particular order
High-throughput Screening (HTS) Market News
- In August 2022, Molbio Diagnostics launched a new test for differential diagnosis of HIV 1 and HIV 2 with viral loads within 60 minutes.
- In July 2022, Evotech Technologies launched the cell analyzer 'Opera' for fast high-content analysis of drug activity with sub-cellular resolution.
- In February 2022, Bruker Corporation launched the timsTOF MALDI PharmaPulse (timsTOF MPP) system, a groundbreaking new high-end solution for unbiased, deep HTS and uHTS based on label-free mass spectrometry.
High-throughput Screening (HTS) Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Open Access to High-throughput Screening Laboratories
4.2.2 Technological Advancements in HTS
4.2.3 Increasing Usage in Universities and Research Centers
4.3 Market Restraints
4.3.1 High Capital Investment
4.3.2 Need for Extensive Automation Techniques
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Technology
5.1.1 Ultra-high-throughput Screening
5.1.2 Cell-based Assays
5.1.3 Lab-on-a-chip
5.1.4 Label-free Technology
5.2 By Applications
5.2.1 Target Identification
5.2.2 Primary Screening
5.2.3 Toxicology
5.3 By Products and Services
5.3.1 Instruments
5.3.2 Reagents and Kits
5.3.3 Services
5.4 By End User
5.4.1 Pharmaceutical and Biotechnology Firms
5.4.2 Academia and Research Institutes
5.4.3 Contract Research Organizations
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle-East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies Inc.
6.1.2 Axxam SpA
6.1.3 Beckman Coulter Inc.
6.1.4 Bio-Rad Laboratories Inc.
6.1.5 Danaher Corporation
6.1.6 GE Healthcare
6.1.7 Merck KGaA
6.1.8 PerkinElmer Inc.
6.1.9 Tecan Group Ltd
6.1.10 Thermo Fisher Scientific Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
High-throughput Screening (HTS) Industry Segmentation
As per the scope of the report, high-throughput screening (HTS) is a technique for conducting scientific experiments that are particularly useful in the drug development process. HTS utilizes robotics liquid handlers, data processing, considerable software, and sensitive detection systems. The High-throughput Screening Market is segmented by Technology (Ultra-high-throughput Screening, Cell-based Assays, Lab-on-a-chip and Label-free Technology), Application (Target Identification, Primary Screening, and Toxicology), Products and Services (Instruments, Reagents, and Kits, and Services), End User (Pharmaceutical and Biotechnology Firms, Academia and Research Institutes and Contract Research Organizations) and Geography (North America, Europe, Asia-Pacific, Middle-East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Technology | |
| Ultra-high-throughput Screening | |
| Cell-based Assays | |
| Lab-on-a-chip | |
| Label-free Technology |
| By Applications | |
| Target Identification | |
| Primary Screening | |
| Toxicology |
| By Products and Services | |
| Instruments | |
| Reagents and Kits | |
| Services |
| By End User | |
| Pharmaceutical and Biotechnology Firms | |
| Academia and Research Institutes | |
| Contract Research Organizations |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
High-throughput Screening (HTS) Market Research FAQs
What is the current Global High-throughput Screening Market size?
The Global High-throughput Screening Market is projected to register a CAGR of 7.80% during the forecast period (2024-2029)
Who are the key players in Global High-throughput Screening Market?
Bio-Rad Laboratories Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., Merck KGaA and Agilent Technologies Inc. are the major companies operating in the Global High-throughput Screening Market.
Which is the fastest growing region in Global High-throughput Screening Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global High-throughput Screening Market?
In 2024, the North America accounts for the largest market share in Global High-throughput Screening Market.
What years does this Global High-throughput Screening Market cover?
The report covers the Global High-throughput Screening Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global High-throughput Screening Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
High Throughput Screening Industry Report
Statistics for the 2024 High Throughput Screening market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. High Throughput Screening analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
